Ikezawa Z, Ikebe T, Ogura H, Odajima H, Kurosaka F, Sase K, Sugiuchi M, Sugiyama A, Suguro H, Suzuki S
Arerugi. 1991 Jun;40(6):633-42.
The usefulness of hypoallergenic rice (HRS-1) was clinically evaluated in 43 patients with severe atopic dermatitis (AD), who were suspected of having rice allergy, in collaboration with 13 hospitals. The patients were fed with HRS-1 instead of eliminating both regular rice and wheat from their daily diet. AD area and severity index (ADASI) was calculated as an indicator of the degree of cutaneous symptoms. Significant decrease of ADASI were observed in the 2nd and 4th week and at the end of the replacement therapy (5.6 weeks on average). On final evaluation, 74% of the patients tested showed "moderate" to "remarkable" improvement, and in 53% of the patients HRS-1 resulted in a "moderate" to "remarkable" reduction in the dosage and the grade of potency of the steroid ointment concomitantly used for the treatment. Finally, HRS-1 was evaluated as "useful" to "very useful" as the elimination diet in 70% of the patients.
我们与13家医院合作,对43名疑似大米过敏的重度特应性皮炎(AD)患者进行了低敏大米(HRS-1)临床疗效评估。这些患者食用HRS-1,而非在日常饮食中同时剔除普通大米和小麦。计算特应性皮炎面积和严重程度指数(ADASI)作为皮肤症状严重程度的指标。在第2周、第4周以及替代治疗结束时(平均5.6周)观察到ADASI显著下降。在最终评估中,74%的受试患者显示“中度”至“显著”改善,53%的患者使用HRS-1后,同时用于治疗的类固醇软膏剂量和效力等级“中度”至“显著”降低。最后,70%的患者将HRS-1评估为作为排除饮食“有用”至“非常有用”。